期刊文献+

原发性血小板增多症转变为急性髓系白血病伴骨髓纤维化1例分析 被引量:1

下载PDF
导出
摘要 患者,女,39岁,主因原发性血小板增多症6年,乏力1个月,于2013年12月9日入我院治疗。 1病程情况 1.1现病史 患者于6年前无明显诱因自觉乏力,当地查血常规WBC、RBC、Hb正常,PLT约为1200×10^9/L,在我院诊断为原发性血小板增多症,予羟基脲+干扰素治疗约3年,间断。复查PLT约600×10^9/L-700×10^9/L,PLT正常后间断羟基脲治疗,未规律监测血常规。
出处 《实用检验医师杂志》 2014年第3期187-188,167,共3页 Chinese Journal of Clinical Pathologist
  • 相关文献

参考文献9

二级参考文献19

  • 1Patel RK, Lea NC, Heneghan MA, et al. Prevalence of the activating JAK2 tylxsine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenternlo'. 2006, 130 : 2031-2038.
  • 2Harrison CN, Green AR. Essential thromboeythaemia. Clin Haemato L, 2006, 19: 439-453.
  • 3Cervantes F, Alvarez-ltrran A, Talarn C, et al. Myelofibros is with my- eloid metaplasia following essential th rombocy thaemia: actuarial proba- bility, presenting ehu'aeteristies and ewlution in a series of 195 patients. Br J Hacmatol 2002,118 : 786-790.
  • 4Passamonti F, Rumi E, Pungolino E, et al. Life expectancy and prog- nostic factol,'s for survival in patients with polycythemiavera and essential thromhoeytheia. Am J Med, 2004, 117: 755-761.
  • 5Tefferi A. Classification, Diagnosis and Management of Myeloprolitera- tire 1)isorders in the JAK2V617Fera. Hematology Am SncHematol Educ Program, 2006,36:240-245.
  • 6VANNUCCHI AM,ANTONIOLI E,GUGLIELMELLI P,et al.Charac-teristics and clinical correlates of MPL515W>L/Kmutation in essen-tial thrombocythemia. Blood . 2008
  • 7JOST E,,do O N,DAHI E,et al.Epigenetic alterations complementmutation of JAK2 tyrosine kinase in patients with BCR/ABL-negativemyeloproliferative disorders. Leukemia . 2007
  • 8LASHO TL,TEFFERI A,HOOD JD,et al.TG101348,a JAK2-selec-tive antagonist,inhibits primary hematopoietic cells derived from my-eloproliferative disorder patients with JAK2V617F,MPLW515K orJAK2 exon 12 mutations as well as mutation negative patients. Leukemia . 2008
  • 9Levine RL,Heaney M.New advances in the pathogeneses and therapy of essential thrombocythemia. Hematology Am Soc Hematol Educ Program . 2008
  • 10Dupont S,Mass A,James C,et al.The JAK2617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera. Blood . 2007

共引文献16

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部